Kelley Kenneth J 4
4 · HALOZYME THERAPEUTICS, INC. · Filed Apr 14, 2021
Insider Transaction Report
Form 4
Kelley Kenneth J
Director
Transactions
- Sale
Common Stock
2021-04-14$45.00/sh−5,000$225,000→ 179,833 total
Footnotes (1)
- [F1]This disposition was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.